LabCorp Raritan LabCorp 69 First Avenue Raritan, NJ 08869-1 800 Account Address Woodson Merrell ee JEFFREY ee New York NY 10065 Age (Y/M/D) Date of Birth Sea sovosyoo | o1v20/s3 | » | "| Patient Address Additional Information 9 E 71ST ST NEW YORK NY 10065 Phone: S77-347-857 UPIN: A62553 daw Hop 19/20/13 14:0 09/20/13 14:00 09/21/13 09/25/13 15:06ET | MERRELL Ww 1023153509 MERRELL Tests Ordered NMR LipoProfile; CBC With Differential/Platelet; Comp. Metabolic Panel (14); PE+Interp(Rfx IFE),S; Lyme Ab/Western Blot Reflex; Iron and TIBC; Testosterone, Free+Weakly Bound; Prolactin; DHFA-Sulfate; Homocyst(e)ine, Plasma; C-Reactive Protein, Cardiac; Hemoglobin Alc; Prostate-Specific Ag, Serum; TSH; Vitamin D, 25-Hydroxy; Uric Acid, Serum; GGT; Insulin; Ambiguous Test Order; Ferritin, Serum; Request Problem TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB NMR LipoProfile LDL Particle Number 01 LDL-P 2111 High nmol/L <1000 01 Low < 1000 Moderate 1000 - 1299 Borderline-High 1300 - 1599 High 1600 - 2000 Very High > 2000 Lipids 01 LDL-C NOTES: mg/dL <100 01 LDL-C cannot be calculated because triglycerides are > 400 mg/dL. Optimal 100 Above optimal 100 - 129 Borderline 130 - 159 High 160 - 189 very high > 189 HDL-C Low mg/dL >=40 01 Triglycerides High mg/dL <150 01 Cholesterol, Total 3 High mg/daL <200 01 ' LDL and HDL Particles 01 HDL-P (Total) 28.7 Low umol/L >= 30.5 01 Small LDL-P 1548 High nmol/L <= 527 01 LDL Size 19.8 Low nm > 20.5 01 -—~ *** INTERPRETATIVE ITNFORMATION*** PARTICLE CONCENTRATION AND SIZE <--Lower CVD Risk Higher CVD Risk--> LDL AND HDL PARTICLES Percentile in Reference Population HDL-P (total) High 75th 50th 25th Low >34.9 *34.9 30.5 26.7 <26.7 | EPSTEIN, JEFFREY | CT 26 3-480-2797-0 | Seq 5515 | 09/25/13 15:06 ET FINAL REPORT Page 1 of 6 This document contains private and confidential health information protected by state and federal law. ©2004-13 Laboratory Corporation of America ® Holdings If you have received this document in error, please call 800-631-5250 All — Laeger EFTA00304964

--=PAGE_BREAK=--

LabCorp Raritan ot Raritan, NJ 08869-1800 Phone: 877-547-6837 Paticnt Name Specimen Number Accourt Number Control Number Date and Time Collected | Date Reported AgetY/M/D) Date of Birth 31143092 CNT31143092 | 09/20/13 14:00] 09/25/13 60/08/00 | 01/20/53 TESTS FLAG TS REFERENCE INTERVAL Small LDL-P Low 25th 50th 75th High <117 117 527 839 >839 LDL Size <-Large (Pattern A)-> <-Small (Pattern B)-> 23.0 20.6 20.5 19.0 Insulin Resistance Score o1 LP-IR Score 100 High <= 45 OL LP-IR Score is inaccurate if patient is non-fasting. The LP-IR Score combines information from lipoprotein particle concentration and size to give improved assessment of insulin resistance and diabetes risk. Small LDL-P, LDL Particle Size, HDL-Particle, and LP-IR Score have been validated by LipoScience but not cleared by US FDA; the clinical utility of these test results has not been fully established. INSULIN RESISTANCE MARKER <--Insulin Sensitive Insulin Resistant--> Percentile in Reference Population Insulin Resistance Score LP-IR Score Low 25th 50th 75th High <27 27 45 63 >63 CBC With Differential/Platelet WBC 6.4 x10E3/uL 3.4 - 10.8 02 RBC 5.24 x1l0E6/uL 4.14 - 5.80 02 Hemoglobin 15.3 g/dL 12.6 - 17.7 02 Hematocrit 43.9 % 37.5 - 51.0 02 MCV 84 f£L 79 - 97 02 MCH 29.2 pg 26.6 ~ 33.0 02 MCHC 34.9 g/dL 31.5 - 35.7 02 RDW 14.3 % 12.3 - 15.4 02 Platelets 269 x10E3/uL 155 - 379 02 Neutrophils 56 % 40 - 74 02 Lymphs 31 % 14 = 46 02 Monocytes 8 % 4-12 02 Eos 4 % 0-5 02 Basos 1 % 0-3 02 Neutrophils (Absolute) 3.6 x10E3/uL 1.4 - 7.0 02 Lymphs (Absolute) 2.0 x10E3/uL 0.7 - 3.1 02 Monocytes (Absolute) 0.5 x10E3/uL 0.1 - 0.9 02 Eos (Absolute) 0.3 x10E3/uL 0.0 - 0.4 02 Baso (Absolute) 0.1 x10E3/uL 0.0 - 0.2 02 Immature Granulocytes 0 % 0-2 02 Immature Grans (Abs) 0.0 x10E3/uL 0.0 - 0.1 02 | EPSTEIN, JEFFREY | C—‘“‘CSC‘*d:SC2© 3-4 BO~2797—O | Seq 5555 J 09/25/13 15:06 ET FINAL REPORT Page 2 of 6 This document contains private and confidential health information protected by state and federal law. ©2004~13 Laboratory Corporation of America ® Holdings If you have received this document in error, please call 800-631-5250 All nace ten sae EFTA00304965

--=PAGE_BREAK=--

LabCorp Raritan LabCorp 69 First Avenue of Raritan, NJ 08869-1800 Phone: 877-547-6837 Patient Specimen Number 7 Account Number Control Number Date and Tune Collected | Date Reported . Agel Y/M/D) Date of Birth 31143092 CNT31143092 | 09/20/13 14:00] 09/25/13 60/08/00 | 01/20/53 INTERVAL LAB Comp. Gteketie Panel (14) Glucose, Serum (103 High) mg/dL 65 - 99 02 BUN 19 mg/dL 8 - 27 02 Creatinine, Serum 0.94 mg/dL 0.76 - 1.27 02 eGFR If NonAfricn Am 88 mL/min/1.73 >59 eGFR If Africn Am 101 mL/min/1.73 >59 BUN/Creatinine Ratio 20 10 - 22 Sodium, Serum 139 mmol/L 134 - 144 02 Potassium, Serum 4.1 mmol/L 3.5 - 5.2 02 Chloride, Serum 98 mmol/L 97 - 108 02 Carbon Dioxide, Total 19 mmol/L 19 - 28 02 Calcium, Serum 10.1 mg/dL 8.6 - 10.2 02 Protein, Total, Serum Ted g/dL 6.0 - 8.5 02 Albumin, Serum 4.5 g/dL 3.6 - 4.8 02 Globulin, Total 2.8 g/dL 1.5 - 4.5 A/G Ratio ee lek — 255 Bilirubin, Total 0.6 mg/dL 0.0 - 1.2 02 Alkaline Phosphatase, S 58 IU/L 44 - 102 02 AST (SGOT) IU/L 0 - 40 02 ALT (SGPT) (a) IU/L 0 - 44 02 PE+Interp(Rfx IFE),S Albumin 4.2 g/dL 3.2 = 5.6 02 Alpha-1-Globulin 0.2 g/dL 0.1 - 0.4 02 Alpha-2-Globulin 0.8 g/dL 0.4 - 1.2 02 Beta Globulin 1.0 g/dL 0.6 - 1.3 02 Gamma Globulin 1.0 g/dL 0.5 - 1.6 02 M-Spike Not Observed g/dL Not Observed 02 Globulin, Total 3.1 g/dL 2.0 - 4.5 A/G Ratio 1.4 0.7 - 2.0 Please note: 02 Protein electrophoresis scan will follow via computer, mail, or courier delivery. Interpretation(See Below) 02 The SPE pattern appears essentially unremarkable. Evidence of monoclonal protein is not apparent. Lyme Ab/Western Blot Reflex Lyme IgG/IgM Ab 0.92 High index 0.00 - 0.90 02 Negative <0.91 Owe Equivocal 0.91 - 1.09 Positive >1.09 Note: The CDC currently advises that Western blot testing be performed following all equivocal or positive EIA results. Final diagnosis should include appropriate clinical findings and a positive EIA which is also positive by Western blot. EPSTEIN, JEFFREY Po 26 3-480-2797-0 | Seq 55i5 | 09/25/13 15:06 ET FINAL REPORT Page 3 of 6 This document contains private and confidential health information protected by state and federal law ©2004-13 Laboratory Corporation of America ® Holdings If you have received this document in error, please call 800-631-5250 ag prran erly EFTA00304966

--=PAGE_BREAK=--

a mi LabCorp Raritan UG on Raritan, NJ 08869-1800 Phone: 877-547-6837 “480-275 EPSTEIN, JEFFREY 263-480-2797-0 31143092 CNT31143092 | 09/20/13 14:00] 09/25/13 | M RESULT TESTS FLAG REFERENCE INTERVAL LAB Lyme Ab Interp.,EIA Equivocal 02 Lyme Ab IgG by WB: 02 IgG P93 Ab. Absent 02 IgG P66 Ab. Absent 02 IgG P58 Ab. Present Abnormal 02 IgG P45 Ab. Absent 02 IgG P41 Ab. Present Abnormal 02 IgG P39 Ab. Absent 02 IgG P30 Ab. Absent 02 IgG P28 Ab. Absent 02 IgG P23 Ab. Absent 02 IgG P18 Ab. Absent 02 Lyme IgG WB Interp. Negative 02 Positive: 5 of the following Borrelia-specific bands: 18,23,28,30,39,41,45,58, 66, and 93. Negative: No bands or banding patterns which do not meet positive criteria. Lyme Ab IgM by WB: 02 IgM P41 Ab. Absent 02 IgM P39 Ab. Absent 02 IgM P23 Ab. Absent 02 Lyme IgM WB Interp. Negative 02 Note: An equivocal or positive EIA result followed by a negative Western Blot result is considered NEGATIVE. An equivocal or positive EIA result followed by a positive Western Blot is considered POSITIVE by the CDC. Positive: 2 of the following bands: 23,39 or 41 Negative: No bands or banding patterns which do not meet positive criteria. Criteria for positivity are those recommended by CDC/ASTPHLD. p23=Osp C, p4i=flagellin Note: Sera from individuals with the following may cross react in the Lyme Western Blot assays: other spirochetal diseases (periodontal disease, leptospirosis, relapsing fever, yaws, and pinta); connective autoimmune (Rheumatoid Arthritis and Systemic Lupus Erythematosus and also individuals with Antinuclear Antibody) ; other infections (Rocky Mountain Spotted Fever; Epstein-Barr Virus, and Cytomegalovirus). Lyme Disease Ab, Quant, IgM <0.91 index 0.00 - 0.90 02 Negative <0.91 EPSTEIN, JEFFREY PC —“CstsSSCSCSC*dS:CSC2 3=480~- 2797-0 SeqQ* 5515 09/25/13 15:06 ET FINAL REPORT Page 4 of 6 This document contains private and confidential health information protected by state and federal law. ©2004-13 Laboratory Corporation of America ® Holdings If you have received this document in error, please call 800-631-5250 All ba Laer er I EFTA00304967

--=PAGE_BREAK=--

Pt aut 4 LabCorp Raritan wos 69 First Avenue LabCorp Ratan, NJ 08869-1800 Phone: 877-547-6837 “480-279 EPSTEIN, 263-480-27 Account Number Control Number Date and Tune Collected Date Reported m Agel YAD) 31143092 CNT31143092 | 09/20/13 14:00] 09/25/13 60/08/00 FLAG REFERENCE INTERVAL LAB Equivocal 0.91 - 1.09 Positive >1.09 Note: IgM levels may peak at 3-6 weeks post infection, then gradually decline. FDA currently advises that Western Blot testing be performed following all equivocal or positive EIA results. Final diagnosis should include appropriate clinical findings and a positive EIA which is also positive by Western Blot. Iron and TIBC Iron Bind.Cap. (TIBC) 329 ug/daL 250 - 450 UIBC 244 ug/dL 150 - 375 02 Iron, Serum 85 ug/dL 40 - 155 02 Iron Saturation 26 % 15 - 55 Testosterone, Free+Weakly Bound Testosterone, Serum 178 Low ng/dL 348 - 1197 02 Prolactin 4.2 ng/mL 4.0 - 15.2 02 DHEA-Sulfate 207.7 ug/dL 51.7 - 295.0 02 **Please note reference interval change** Homocyst(e)ine, Plasma 12.8 umol/L 0.0 - 15.0 02 C-Reactive Protein, Cardiac 1.04 mg/L 0.00 - 3.00 02 Relative Risk for Future Cardiovascular Event Low <1.00 Average 1.00 - 3.00 High >3.00 Hemoglobin Alc (s. High % 4.8 - 5.6 02 Increased risk for diabetes: 5.7 - 6.4 Diabetes: >6.4 Glycemic control for adults with diabetes: <7.0 Prostate-Specific Ag, Serum Prostate Specific Ag, Serum 0.8 ng/mL 0.0 - 4.0 02 Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory PSA value 0.2 ng/mL or greater. EPSTEIN, JEFFREY P| 26 3-480-2797-0 09/25/13 15:06 ET FINAL REPORT Page 5 of 6 This document contains private and confidential health information protected by state and federal law. ©2004-13 Laboratory Corporation of America ® Holdings If you have received this document in error, please call 800-631-5250 all Rigits _—_ or EFTA00304968

--=PAGE_BREAK=--

LabCorp Raritan of Raritan, NJ 08869-1800 Phone: 877-547-6837 Pabent Name Specimen Number 263-480-2797-0 —_ = |_ == ssssal= 0708/00 | 01/2075: 31143092 NT31143092 | 09/20/13 14:00 09/25/13 60/08/00 | 01/20/53 (ars __Regucr FLAG UNIS REFERENCE INTERVAL TAB] Values obtained with different assay methods or kits cannot be used interchangeably. Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease. TSH 1.680 ulU/mL 0.450 - 4.500 02 Vitamin D, 25-Hydroxy 41.4 ng/mL 30.0 - 100.0 02 Vitamin D deficiency has been defined by the Institute of Medicine and an Endocrine Society practice guideline as a level of serum 25-OH vitamin D less than 20 ng/mL (1,2). The Endocrine Society went on to further define vitamin D insufficiency as a level between 21 and 29 ng/mL (2). 1. IOM (Institute of Medicine). 2010. Dietary reference intakes for calcium and D. Washington DC: The National Academies Press. 2. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. JCEM. 2011 Jul; 96(7):1911-30. Uric Acid, Serum Uric Acid, Serum 7.1 mg/dL 3.7 ~ 8.6 02 Please Note: 02 Therapeutic target for gout patients: <6.0 GGT 18 IU/L 0 - 65 02 Insulin (6.y High ulU/mL 2.6 - 24.9 02 Ambiguous Test Order 02 Attempts to contact your facility to clarify an ambiguous test order were unsuccessful. Please contact the laboratory to verify the request. Specimens blaninpe held for 7 days from date of receipt. Ambiguous test order bho of feb wb.) 028240 Ferritin, Serum 121 ng/mL 30 - 400 02 Request Problem 03 Test Not Performed. Specimen is lipemic. TEST: 143257 Testost., % Free+Weakly Bound Panel: 143255 LipoScience Ine Dir: Deanna Franke, PhD 2500 Sumner Blvd, Raleigh, NC 27616-3235 02 LabCorp Raritan Dir: Araceli B Reyes, MD 69 First Avenue, Raritan, NJ 08869-1800 03 BN LabCorp Burlington Dir: William F Hancock, MD 1447 York Court, Burlington, NC 27215-3361 Por inquiries, the physician may contact Branch: 800-631-5250 Lab: 877-547-6837 [ EPSTEIN, JEFFREY J | 263 -480-2797-0 | Seat 5515 | 09/25/13 15:06 ET FINAL REPORT Page 6 of 6 ‘This document contains private and confidential health information protected by state and federal law ©2004-1353 Laboratory Corporation of America ® Holdings If you have received this document in error, please call 800-631-5250 All Let Te er: EFTA00304969

--=PAGE_BREAK=--

— Laboratory Corporation of America gw Special Chemistry Department quy Raritan, New Jersey Serum Protein Electrophoresis Specimen Number 263480279706 Account No. /Name: 31143092-Woodson Merrell Total Protein: 7.3 DID: Patient Name: EPSTEIN, JEFFREY Account Address 1: Patient Id: Account Address 2: 44 E 67th st Birthdate: 20-JAN-1953 Account Address 3: New York, NY 10065 [a | SPIFE SPE Split Beta Sample 9 09-23-2013 12:45:08:08 ; Status: Ok Fraction % g/dL g/dL Range Albumin 58.1 4.2 3.2 5.6 Alpha 1 2.7 0.2 0.1 0.4 Alpha 2 11.2 0.8 0.4 1.2 Beta 13.9 1.0 0.6 1.3 Gamma 14.1 1.0 0.5 1.6 Total 7.3 6.0 8.5 Comment The SPE pattern appears essentially unremarkable. Evidence of monoclonal protein is not apparent. EFTA00304970

--=PAGE_BREAK=--

LabCorp Raritan 69 First Avenue Raritan, NJ 08869-1800 Phone: 800-631-5250 Specimen Number Coetrol Number Accoumt Number Account Phone Number Route aesnaso-a7s7-1 || carr tatt3000 | Sitaboa2 | 2293S Yor | 0 | Patient Last Name Account Address Woodson Merrell Patient First Name Patient Middle Name JEFFREY es Se | Age (Y/MUD) Date of Barth sovosyoo | oiszo/s3 | w | "| Patient Address 44 E 67th St New York NY 10065 Additional Information 9 E 71ST ST NEW YORK NY 10065 UPIN: A62553 09/20/13 14:00 09/25/13 09/26/13 09:05ET | MERRELL w 1023153509 MERRELL Tests Ordered FSH and LH; Written Authorization TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB FSH and LH LH Pe | mIU/mL 1.7 - 8.6 01 FSH 4.5 mIU/mL 1.5 - 12.4 01 Written Authorization Written Authorization Received. 01 Authorization received from SIGNATURE FILE 09-25-2013 Logged by Anca Orban RN LabCorp Raritan Dir: Araceli B Reyes, MD 69 First Avenue, Raritan, NJ 08869-1800 iries, the physician may contact Branch: 800-631-5250 Lab: 800-631-5250 | EPSTEIN, JEFFREY | Cd 263-4 80~ 2797-1 09/26/13 09:06 ET FINAL REPORT Page 1 of 1 This document contains private and confidential health information protected by state and federal law ©2004-13 Laboratory Corporation of America @ Holdings If you have received this document in error, please call 800-631-5250 Alt Ries Reserved boc er EFTAOQO Wr \ OM ow yo 304971

--=PAGE_BREAK=--

LabCorp Raritan 69 First Avenue Raritan, NJ 08869-1800 Phone: 800-762-4344 Specemen Number Control Number Account Number Account Phone Number Route agsaso-sa35-0 | | comsiazoo2 | Sinasooa | 2i7%s35-toi2 | So | Patient Last Name Account Address EPSTEIN Woodson Merrell JEFFREY Age CY? mai 60/08/00 | 01/20/53 | w | "| Patent Adiiress Additional Information 44 E 67th St New York NY 10065 9 EAST 71ST ST NEW YORK NY 10065 UPIN: A62553 09/20/13 14:00 09/21/13 09/26/13 09:05ET | MERRELL We 1023153509 Teas Ordered Lp-PLA2 TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB Lp-PLA2 137 ng/mL 131 - 199 01 Low Risk <200 Moderate Risk 200 - 235 High Risk 3235 01 BN LabCorp Burlington Dir: William F Hancock, MD 1447 York Court, Burlington, NC 27215-3361 For inguiries, the physician may contact Branch: 800-631-5250 Lab: 800-762-4344 EPSTEIN, JEFFREY po 263-48 0-3235-0 09/26/13 09:06 ET FINAL REPORT Page 1 of 1 This document contains private and confidential health formation protected by state and federal law ©2004~13 Laboratory Corporation of America ® Holdings If you have received this document in error, please call 800-631-5250 All near map er EFTA00304972

--=PAGE_BREAK=--

LabCorp Raritan 69 First Avenue Unbevatery Raritan, NJ 08869-1800 Phone: 800-444-9111 Species Nenber Control Number Accoum Number Account Phone Number Route 263-480-3234-0 cussinds0e2 | 32143092 Patient Last Name coun Address Woodson Merrell Age (Y/ MD) ie of Bi Sex Panent Adkiress 44 E 67th St New York NY 10065 Ackinteonal Information 9 EAST 71ST NEW YORK NY 10021 UPIN: A62553 Physician ID Tests Ordered Dihydrotestosterone TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB Dihydrotestosterone Dihydrotestosterone 16 Low ng/daL 01 Reference Range: Adult Male: 30 - 85 01 ES Esoterix Endocrinology Dir: Samuel Pepkowitz, MD 4301 Lost Hills Road, Calabasas Hills, CA 91301-5358 For inguiries, the physi contact Branch: 800-631-5250 Lab: 800-444-9111 | EPSTEIN, JEFFREY [263-48 0-3234-0 | Seq 5509 09/25/13 09:05 ET FINAL REPORT Page 1 of 1 This document contains private and confidential health information protected by state and federal law ©2004-13 Laboratory Corporation of America ® Holdings If you have received this document in error, please call 800-631-5250 All Rights Reserved DOC! Ver 1.49 EFTA00304973

--=PAGE_BREAK=--

LabCorp Raritan 69 First Avenue Raritan, NJ 08869-1800 Phone: 800-631-5250 Specumen Number Control Number Account Nuimber Account Phone Number Route 263-042-7600-0 Paticnt Last Name Account Adress Woodson Merrell erry JEFFREY jal haen Age (Y/M/D) Date of Barth Sea sovos/oo | o1720/s3 | » | No | Parent Address 44 E 67th St New York NY 10065 Adklitional Information 09/20/13 14:00 09/21/13 09/21/13 15:05ET MERRELL Tests Ordered Fibrinogen Activit TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB Fibrinogen Activity 355 mg/dL 193 - 507 01 Specimen was ultracentrifuged before testing to remove extreme lipemia. Results should be interpreted with caution. ol RN LabCorp Raritan Dir: Araceli B Reyes, MD 69 First Avenue, Raritan, NJ 08869-1800 For inquiries, the physician may contact Branch: 800-631-5250 Lab: 800-631-5250 EPSTEIN, JEFFREY Po 26 3-042-7600~0 09/21/13 15:06 ET FINAL REPORT Page 1 of 1 ‘This document contains private and confidential health information protected by state and federal law. ©2004—13 Laboratory Corporation of America ® Holdings If you have received this document in error, please call 800-631-5250 All Rights Reserved DOCI Ver: 1.49 EFTA00304974

--=PAGE_BREAK=--

LabCorp Raritan LabCorp 69 First Avenue of Raritan, NJ 08869-1800 Phone: 800-631-5250 Specimes Number Coetrot Number Account Number Accout Phone Number Route assasona7ee-0 | | crs ta3002 | Siiadoa3 | S19%3S-Y012 | “io | Parent Last Narne Account Address EPSTEIN Woodson Merrell — | tll [alah New York NY 10065 Age (YOUD) Date of Birth Sea 60/08/00 | 01/20/53 Patient Address, Additiomal Information 09/20/13 00:00 09/21/13 09/21/13 15:05ET MERRELL Ca+PTH Intact TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB Ca+PTH Intact Calcium, Serum 9.6 ( mg/dL 8.6 - 10.2 01 PTH, Intact 43 \ pg/mL 15 - 65 01 Intact PTH —— 01 Interpretation Intact PTH Calcium (pg/mL) (mg/dL) Normal 15 - 65 8.6 - 10.2 Primary Hyperparathyroidism >65 >10.2 Secondary Hyperparathyroidism >65 <10.2 Non-Parathyroid Hypercalcemia <65 >10.2 Hypoparathyroidism <15 < 8.6 Non-Parathyroid Hypocalcemia 15 - 65 < 8.6 01 RN LabCorp Raritan Dir: Araceli B Reyes, MD 69 First Avenue, Raritan, NJ 08869-1800 For inquiries, the physician may contact Branch: 800-631-5250 Lab: 800-631-5250 EPSTEIN, JEFFREY po 26 3 ~-480-2784~-0 09/21/13 15:06 ET FINAL REPORT Page 1 of 1 This document contains private and confidential health information protected by state and federal law ©2004-13 Laboratory Corporation of America ® Holdings If you have received this document in error, please call 800-631-5250 All Righs Reserved en ll EFTA00304975

--=PAGE_BREAK=--

LabCorp Raritan 69 First Avenue Raritan, NJ 08869-1800 Phone: 800-762-4344 aes-aso-33a6-0 | cass tta3092 | 32243092 | 2i2'sas-1012 | ‘ro Patient Last Name Account Address EPSTEIN Woodson Merrell Patient Firt Name Patient Middle Name JEFFREY Total Volume 44 FE 67th St Age (Y/M/D) Date of Birth Se Fasting New York NY 10065 60/08/00 01/20/53 M No Patient Address Adkitional Information 09/20/13 14:00 09/21/13 09/23/13 09:05ET MERRELL Tests Ordered IGF-1 TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB IGF-1 Insulin-Like Growth Factor I 127 ng/mL 51 - 194 o1 BN LabCorp Burlington Dir: William F Hancock, MD 1447 York Court, Burlington, NC 27215-3361 For inquiries, the physician may contact Branch: 800-631-5250 Lab: 800-762-4344 EPSTEIN, JEFFREY Po 263-4 80- 3346-0 09/23/13 09:05 ET FINAL REPORT Page 1 of 1 This document contains private and confidential health information protected by state and federal law ©2004—13 Laboratory Corporation of America @ Holdings If you have received this document in error, please call 800-631-5250 All seco vennas “1 Ver: I. EFTA00304976